title: Quenching the thirst in dialysis patients.
abstract: In a double-blind cross-over trial, 22 stable end-stage renal failure patients on maintenance haemodialysis were subjected to conventional dialysis with dialysate containing 137 mEq/l sodium and constant ultrafiltration (UF) and to a different dialysis therapy, in which, by linear sodium modelling, the dialysate sodium was reduced from 137 to 128 mEq/l. A computerized UF program was used to gradually reduce the UF to a minimum towards the end of the session. Severity of thirst, interdialytic weight gain and intradialytic complications were less with low sodium dialysate. It allowed adequate UF with absolute hemodynamic stability. The reduced incidence of complication with low sodium dialysate therapy was probably because they required less UF.
authors.affiliation: Department of Nephrology, Kidwai Memorial Institute of Oncology, St. Johns' Medical College, Bangalore, India.
authors.forename: S C
authors.initials: SC
authors.lastname: Dominic
authors.forename: S
authors.initials: S
authors.lastname: Ramachandran
authors.forename: S
authors.initials: S
authors.lastname: Somiah
authors.forename: K
authors.initials: K
authors.lastname: Mani
authors.forename: S S
authors.initials: SS
authors.lastname: Dominic
mesh_terms: D000328:Adult; D018592:Cross-Over Studies; D004311:Double-Blind Method; D005260:Female; D006801:Humans; D007676:Kidney Failure, Chronic / Q000150:complications* / Q000628:therapy; D008297:Male; D008875:Middle Aged; D006435:Renal Dialysis / Q000009:adverse effects*; D012964:Sodium / Q000097:blood / Q000378:metabolism; D013894:Thirst / Q000502:physiology*; D015430:Weight Gain / Q000502:physiology
chemical_list: D012964:Sodium